Our Indiana Kelley – SKK GSB Executive MBA alumna, Misun Yang (EMBA 2021), General Manager of Ipsen Korea, was interviewed on SBS Biz TV.

"Rare, but never light — the burden of rare disease is real."
As General Manager of Ipsen Korea, she explained how the company has introduced a new drug for a rare disease in Korea and how Ipsen Korea takes on diseases that previously had no treatment options.

Misun highlighted, "94% of rare diseases still have no treatment. And even for the 6% that do, many patients face barriers to access."

She concluded her interview, saying, "With Korea's world-class hospital infrastructure and clinical research capabilities, Ipsen Korea aims to position the country as a strategic hub for global drug development."

Misun is a marketing expert with a 20-year career in the pharmaceutical industry, including MSD Korea, AstraZeneca Korea, and Gilead Sciences Korea. Recognized for her expertise, she was appointed General Manager of Ipsen Korea last year. Ipsen is a global pharmaceutical company that was founded 100 years ago in France.